Esperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports Third Quarter 2016 Financial Results
03 nov. 2016 16h05 HE
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), a pharmaceutical company focused on developing and commercializing oral therapies for the treatment...
Vocera Announces Third Quarter Revenue of $33.8 million and Raises FY’16 Revenue Guidance
27 oct. 2016 16h06 HE
|
Vocera Communications
SAN JOSE, Calif., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Vocera Communications, Inc. (NYSE:VCRA), the leading healthcare communications company, today reported total revenue of $33.8 million, an...
Vocera Q3 2016 Results to be Released October 27, 2016
13 oct. 2016 08h00 HE
|
Vocera Communications
SAN JOSE, Calif., Oct. 13, 2016 (GLOBE NEWSWIRE) -- Vocera Communications, Inc. (NYSE:VCRA) today announced that it expects to release results for its third quarter 2016 on Thursday, Oct. 27,...
Lexington Realty Trust to Report Third Quarter 2016 Financial Results on November 3, 2016
11 oct. 2016 16h20 HE
|
Lexington Realty Trust
NEW YORK, Oct. 11, 2016 (GLOBE NEWSWIRE) -- Lexington Realty Trust (NYSE:LXP) (“Lexington”), a real estate investment trust (REIT) focused on single-tenant real estate investments, today announced...